Clinical Trial Update: Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

Akouos, Inc. is conducting a Phase 1/2 gene therapy trial for otoferlin-mediated sensorineural hearing loss. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• AK-OTOF gene therapy

Snippet

Sponsor: Akouos, Inc. | Conditions: Sensorineural Hearing Loss, Bilateral | Phase 1, Phase 2 | Status: RECRUITING